CELL CULTURE BIOREACTOR WITH ZONE CONTROL
A cell culture bioreactor has membranes divided into a plurality of zones. The membranes may include perfusion membranes carrying a liquid media and/or gas transfer membranes. The bioreactor has one or more sensors configured to collect data from one or more locations within the bioreactor. The supply of one or more of the gaseous and/or liquid media to a selected zone or zones may be controlled. In some examples, the supply includes a background supply and a selectable incremental supply. The bioreactor may be used to grow cells in suspension. Liquid media circulates within an extra-capillary space of the bioreactor. In some examples, a portion of cells is permitted for a period of time to be restrained within one or more zones of the membranes. Elements of a reactor may be made in a mold. A reactor may be operated in a fed-batch process.
This specification claims priority to, and the benefit of, U.S. Provisional patent Application No. 62/970,305, Cell Culture Bioreactor With Zone Control, filed on Feb. 5, 2020, and U.S. Provisional Patent Application No. 63/002,504, Cell Culture Bioreactor For Suspension Culture, filed on Mar. 31, 2020, both of which are incorporated by reference.
FIELDThis specification relates to cell culture and cell culture bioreactors.
BACKGROUNDThe following is not an admission that anything discussed below is common general knowledge or citable as prior art.
The term “cell culture” is sometimes used to refer to the culture of any cells and sometimes specifically to the culture of eukaryotes. In this specification, unless stated otherwise, cell culture includes the culture of any cells including a) eukaryotes, for example animal cells such as mammalian cells, b) non-eukaryotes such as bacteria or eukaryotic organisms such as yeasts, fungi or protozoa (sometimes referred to as “microbial culture”) and c) plant cells (sometimes referred to as “plant cell culture” or “tissue plant cell culture”). Further, cell culture as used in this specification, unless stated otherwise, includes growing cells for the purpose of obtaining the cells themselves and growing cells for the purpose of obtaining a product produced by the cells, for example a genetic material, protein, peptide or enzyme. This is in contrast to growing cells primarily for the purpose of consuming a pollutant as in wastewater treatment.
In some cell culture bioreactors, a nutrient medium flows through the lumens of hollow fiber membranes to provide a perfusion culture mode wherein nutrients diffuse through pores of the membranes to cells growing in the outside of the membranes, optionally called the extra-capillary space (ECS).
INTRODUCTIONThe following introduction is not intended to limit or define the claims.
This specification describes a cell culture bioreactor having a plurality of zones. Each of the zones has one or more membranes. Some of the membranes may be perfusion membranes carrying a liquid media. The liquid media may be used to supply and/or remove liquid, dissolved or dispersed (i.e. solid) compounds. Some of the membranes may be gas transfer membranes carrying a gaseous media. The gaseous media may be used to supply and/or remove one or more gasses, which may include vapors. Optionally, some zones may intersect with other zones to form compound zones. For example, a zone of perfusion membranes may intersect a zone of gas transfer membranes.
The specification also describes a bioreactor having one or more sensors configured to collect data from one or more locations within the bioreactor. In some examples, data is collected from an array of locations. In some examples, data is collected through transparent parts or windows of the bioreactor. In some examples, the cell culture bioreactor also has a plurality of zones as described above. The data collection locations can be associated with, or mapped to, the zones.
This specification also describes a fluid control module. The fluid control module connects one or more ports to a plurality of control areas. The fluid control module has valves or other flow control devices that allow the flow of a fluid stream between a port and a selected control area to be varied. The variation may be relative to a flow provided at a different time and/or relative to a flow rate provided to a different area. In some examples, a control area is connected to two or more ports of a fluid control module. Optionally, the connection between a control area and one of multiple ports may be uncontrolled. Optionally the flow to or from a port may be controlled externally to the fluid control module. In some examples, one or more fluid control modules are combined with a bioreactor having a plurality of zones as described above. One or more outlet areas of one or more fluid control modules may be associated with one or more zones of the bioreactor.
This specification also describes a process for operating a bioreactor. The process includes controlling the supply of one or more gaseous and/or a liquid media to zones of a bioreactor. In some examples, data associated with the zones is collected. The data may be considered in determining a flow of gas or liquid media to be provided to one or more zones of the bioreactor. In some examples, the determinations may be made according to an algorithm or other programmed or automated control process. Optionally, the process may involve multiple bioreactors in a multi-stage process. The process may be, for example, a batch, fed-batch or continuous process. The process may be used to grow various cell types to produce a cellular or whole cell product.
In some examples of a cell culture process, first media is provided in a portion of the ECS of the reactor, and later first media is provided in a larger portion of the ECS of the reactor. Gas and/or second media is supplied to elements of the reactor while they are immersed in first media.
This specification also describes a system. The system includes a bioreactor with a plurality of zones, one or more sensors, one or more fluid control devices and a controller. One or more of the bioreactor, sensors and fluid control devices may be as described above. The controller may be a computer, for example a general purpose computer or a programmable logic controller.
This specification also describes a method and bioreactor for growing cells in suspension, in aggregates within a membrane matrix, adhering to a membrane, or simultaneously in a combination of these modes. The apparatus includes hollow fiber membranes. Liquid media circulates within an extra-capillary space of the bioreactor. The circulation may be provided by, for example, a mixer, forced flow of liquid through the extra-capillary space, or movement of the bioreactor, for example by rotating the bioreactor. One or more of the membrane diameter, membrane spacing, membrane packing density, the arrangement of the membrane into zones, the slack or taut mounting of the membranes, or the orientation of the membranes may be selected to assist in the circulation. In some examples of a process, a portion of the cells in a bioreactor is permitted for a period of time to be restrained within one or more zones of the membranes.
This specification also describes a bioreactor and a method of making a bioreactor. An interim construct of the bioreactor may have a mold and membrane plate assemblies mounted in the mold. The hollow fiber membranes may be regularly spaced apart in the membrane plate assemblies. The mold and the membrane plate assemblies may have cooperating features that locate the membrane plate assemblies within the mold. The mold may have apertures in surfaces of the mold generally parallel with the membranes and/or panels in surfaces of the mold generally perpendicular to the membranes. The panels may separate potting cavities defined by the mold. In a further construct, solidified potting material seals the ends of the membranes in one or more potting cavities. In a further construct, portions of the potting material and mold are removed to expose the lumens of the membranes at the ends of the membranes. Caps may be placed over the ends of the membranes providing one or more ports in communication with the lumens of the membranes. An aperture of one construct as described may be connected to the aperture of another such construct, to a top plate, to a base plate, to a mixing layer or to a harvest layer.
In a process, one or more membrane plate assemblies are placed and located in a first part of a mold. A second part of the mold is added to enclose potting cavities around ends of the membrane plate assemblies. A liquid potting resin is added to the potting cavities and cured. A portion of the mold and potting material is removed to expose the lumens of the membranes. The exposed lumens of the membranes may be connected to a gas supply system or to a liquid media supply system. The mold may have apertures in surfaces of the mold generally parallel with the membranes and/or panels in surfaces of the mold generally perpendicular to the membranes, which remain with a resulting element when the portion of the mold and potting material are removed. The apertures of an element may be connected to a top plate, a base plate, another element, a mixing layer or a harvest layer to provide a bioreactor of a selected configuration.
PCT application number PCT/CA2019/051397, called Cell Culture Bioreactor and filed on Sep. 30, 2019, describes a cell culture bioreactor and methods of making it. This application is incorporated herein by reference. Various elements of the bioreactor described herein may be made according to the description in PCT application number PCT/CA2019/051397. One or more of the inventions described herein may also be adapted to other bioreactors described in PCT application number PCT/CA2019/051397 or other types of bioreactors known in the art.
The membranes 102 are potted in potting heads 142, alternatively called potting blocks. The potting heads 142 are optionally made of an epoxy or polyurethane resin, optionally cast in place around ends of the membranes 102 as the membranes 102 are rotated within a mold. Lumens 144 of the membranes 102 are open to a face of at least one potting head 142. For example, a radially outward portion of each potting head 142 may be cut away to expose the lumens 144 at open ends of the membranes 102. Portions of braces 114 that were inserted in the mold may be cut away with parts of the potting heads 142, but parts of the braces 114 remain to connect remaining parts of the potting heads 142 together. The braces 114 may be transparent.
Optionally, lumens 144 of the membranes 102 are open at both ends to faces of two potting heads 142. Optionally, the membranes 102 potted into a particular potting head 142 may be separated into zones. Zones may be separated from each other vertically, horizontally, or in other directions. In the example shown, the perfusion membranes 102a are divided horizontally (i.e. separated by a vertical line) into two zones, 104 and 106. The gas transfer membranes 102b are also divided into two zones 108 and 110. The intersection of these zones produces four compound zones within the element 140, in particular zones 104/108; 104/110; 106/108; and, 106/110. In another example, the membranes 102a and/or 102b might also be divided vertically (i.e. separated by a horizontal line) to produce a two by two grid of four zones for each type of membrane 102a and 102b. The intersections of these zones would produce eight zones within the element 140. Other examples may have other vertical and/or horizontal divisions producing more or less zones.
The reactor 150 also includes a top 154 and a base 156. The elements 140 can be sealed together and to the top 154 and the base 156 by an adhesive or through gaskets 152. If gaskets 152 are used, they may be compressed by placing the reactor 150 in a frame (not shown) or placing bolts through the reactor 150. The base 156 contains a well 158 with a mixer 160, shown also in
The bioreactor 150 has a set of fluid control modules 151. In the example shown, a fluid control module 151 covers one side of each of three elements 140, which make up one side of the bioreactor 150. In other examples, a fluid control module 151 may cover more or less elements 140. Optionally, multiple fluid control modules 151 may be placed on a side of a bioreactor 150. In the example shown, a fluid control module 151 is placed on each of two sides of the bioreactor 150, in communication with one end of each type of membrane 102a, 102b. In other examples, the bioreactor 150 may have fluid control modules 151 on more or less of its sides or on different sides. For example, fluid control modules 151 may be associated with only one set of membranes 102a, 102b. In other alternatives, fluid control modules 151 may be placed on both ends of either or both sets of membranes 102a, 102b.
In the example shown, a fluid control module 151 has two ports 149a, and 149b. In other examples a fluid control module 151 may have more or less ports 149. A fluid control module 151 also has a control conduit 170. In the example shown, the control conduit 170 is a bundle of electrically conductive wires. In other examples, the control conduit may contain one or more wires, fiber optic cables, pneumatic tubes, hydraulic tubes or other conduits capable of carrying a signal. In other examples the control conduit 170 is replaced by an electromagnetic receiver, such as a Bluetooth receiver. In some examples, the fluid control module 151 may also be connected to a power supply, for example an electrical power supply.
In the example shown, the bioreactor 150 has twelve compound zones. The four compound zones within each element 140, i.e. zones 104/108; 104/110; 106/108; and, 106/110, are repeated in each of the three elements 140. On each side of the bioreactor 150, the lumens 144 of six sets of membranes 102, one set on the left side and one set on the right side of each of three elements 140, are accessible. In other examples the bioreactor 150 may have more or less zones and more or less sets of membranes 102 accessible from any particular side of the bioreactor 150. For example, a bioreactor 150 may have more or less than three elements 140. Alternatively or additionally, an element 140 may have more or less than four zones or more or less than four compound zones.
Each control zone 200 has one or more openings 204. The openings 204 are fluidly connected to the ports 149.
The flow through a zone 104, 106, 108, 110 may be controlled by a fluid control module 151 on the upstream end, downstream end, or the both upstream and downstream ends of a zone 104, 106, 108, 110. If a fluid control module 151 is provided only on one side of a zone 104, 106, 108, 110, then the other side of the zone 104, 106, 108, 110 may be covered with a cap, manifold or header connected to an inlet or outlet port.
A fluid control module 151 may alternatively have ports 149 connected to openings 204 in only some of the control areas 200. In this way, a fluid may flow into some control areas and out of other control areas. Accordingly, the flow in a zone 104, 106, 108, 110 of one element 140 may be in the same direction or the opposite direction compared to the corresponding zone 104, 106, 108, 110 in another element 140 of the bioreactor 150. For example, as shown in
Optionally, a fluid control module 151 may have heating elements or cooling elements. The heating or cooling elements may heat or cool the outside of the bioreactor 151 or a heat or cool a fluid entering the bioreactor. In some example, each control area 200 has a heater element. Optionally, the heating elements may be individually controlled. Heating or cooling a fluid entering the bioreactor may advantageously adjust the temperature throughout the ECS rather than only on the walls of the reactor 150.
Referring to
One or more pumps 230 are connected to the container 222 to pump the liquid media 220. A pump 230 may be, for example, a peristaltic or other pump. A pump 230 may be connected to a variable frequency drive, inlet valve, outlet valve or other controllable device to allow the pressure and or flow at the outlet of the pump 230 to be controlled. Container 222 may be, optionally, an open tank or a sealed vessel. A pump 230 may be, optionally, upstream or downstream of the container 222. If a pump 230 is upstream of the container 222, the container 222 may be connected to the corresponding port 149 of the flow control module 151 by a conduit without a pump 230. The container 222 may be located above or below the zone 104. By manipulating these various options, the pressure inside of the membranes 102 may be above or below the pressure in the extra-capillary space of the zone 104 as required for the applicable cell growth process. The liquid media supply system for the reactor may be protected from contamination by having any connections to the atmosphere protected by vent filters. The membranes 102 themselves further protect the ECS from contamination. The reactor 150 and associated equipment are preferably sterilized before use, for example by steam (autoclave), gamma radiation, alcohol or other methods.
In the example shown, fluid control modules 151 are in communication with the upstream and downstream ends of the zone 104. Alternatively, only one fluid control module 151 may be used, in communication with either the upstream or downstream ends of the zone 104. Pump 230b produces a flow less than the flow produced by pump 230a. For example, pump 230b may produce 5-25% of the flow of pump 230a. Opening or closing valve 206 on the upstream side of the zone 104 thereby increases or decreases the flow of liquid media 220 through the zone 104.
Optionally, ports 149b are smaller than ports 149a. The port 149b on the downstream side of the zone 104 may be connected to the inlet of pump 230a as shown or alternately to the container 222 or the inlet side of pump 230b. Opening valve 206 downstream of the zone 104 may therefore do one or more of: increase the flow through zone 104, decrease the flow through zone 104, increase the pressure inside of membranes 102 or decrease the pressure inside of membranes 102. Four flow states are available depending on the positions of the two valves 206.
Referring back to
Measurements of various parameters are made at various points in the bioreactor 150 at various times. The measurements are sent to a controller, for example a computer. The controller may be programmed with a digital model of the bioreactor 150. The controller may estimate the parameters at other points or times in the bioreactor. The controller may adjust the flow through one or more zones 104, 106, 108, 110 to correct conditions observed into the bioreactor 150 and/or to improve future conditions in the bioreactor 150.
In some examples, measurements are taken in a three-dimensional array. For example, measurements are taken at each of four braces 114 of each element 140. These measurements are exported to a computerized model of the bioreactor 150. The module may be analyzed to estimate one or more parameters at one or more positions within the bioreactor 150 that are not measurement locations. The model may also be analyzed to extract past trends, to predict future states and/or to predict the effect of changes in the pressure and/or flow of liquid and/or gaseous media to one or more zones of the bioreactor 150. The model may be combined with a controller programmed to make changes in the pressure and/or flow of liquid and/or gaseous media to one or more zones of the bioreactor 150 predicted to provide a desired condition within the bioreactor 150.
Some or all of the layers 140, 300, 302 have sensors. In the example shown, a set of sensor strips 308 extends vertically along the insides of the braces 114 of the layers 140, 300, 302. Each sensor strip 308 is an elongated section of an optical sensor foil as described above. The sensor strips 308 may include a dissolved carbon dioxide sensor, a dissolved oxygen sensor and a pH sensor. The sensor strips 308 give off a signal when interrogated with a detector unit through the braces 114, which are transparent. The detector unit may have, for example, a source of light of one or more peak wavelengths, a camera (i.e. CMOS or CCD) chip and optionally one or more optical filters. Optionally, the VisiSens TD™ modular mapping system from PreSens may be used as the detector unit. Optionally, different sensors are provided in different locations of the reactor.
The bioreactor 150 may be used, for example, to grow whole cell products or cellular therapeutic products. In some examples, the bioreactor 150 is used to grow red blood cells or red blood cell therapeutics. The term red blood cells (RBCs) will be used herein, unless the context indicates otherwise, to include RBCs and any of their precursors such as hematopoietic stem cells (i.e. CD34+ cells optionally obtained from bone marrow, peripheral blood or cord blood), a partially differentiated cell line derived from CD34+ cells, nucleated precursor cells or enucleated RBCs. A partially differentiated cell line may be grown, i.e. expanded, in a bioreactor 150. Optionally, partially differentiated cells may be converted into nucleated precursor cells and/or enucleated RBCs in a bioreactor 150. In other examples, one or more of steps of differentiation or enucleation occur outside of the bioreactor 150. The RBCs may be manufactured with fewer antigens belonging to clinically significant blood groups such as ABO, Rh, Kell, Duffy, Kidd, MNS, P1, etc. than typical red blood cells taken from a human donor, or with a specific combination of antigens. The manufactured RBCs may be suitable for inhibiting alloantibody formation (i.e. alloimmunization), which may be useful for repeat transfusion applications. The manufactured red blood cells may also be perceived by the patient to have a relatively young cell age, for example 20 days or less, compared to an average cell age of about 60 days for typical blood from a human donor, which may allow them to persist longer in vivo. The RBC manufacturing process can include expanding a population of stem cells or partially differentiated cells, transforming the stem cells or differentiated cells into RBCs, and enucleating the RBCs. The expansion of precursor cells and transformation of the red blood cells can be controlled by one or more genetic switches. Enucleation can be facilitated, for example, by filtering the nucleated RBCs through pores sized to require ejection of the nucleus to pass through.
In the bioreactor 150, cells, optionally in suspension alone or attached to carriers or attached to or retained by the membranes 102, receive nutrients through the perfusion membranes 102a and receive oxygen through the gas transfer membranes 102b. Optionally, soluble or dispersed waste products of the cells may be removed through the perfusion membranes 102a. A first media is added to the extra-capillary space of the bioreactor 150. Optionally, the first liquid media is circulated through the ECS. A second liquid media (i.e. liquid media 220 described above) is circulated through the lumens 144 of the perfusion membranes 102a. The second media may be the same as the first media or a different media. The first and/or second media may be a manufactured media, which may be derived from serum or not. The first and/or second media may have a reduced concentration of growth factors compared to conventional cell culture media. The first and/or second media may have one or more proteins replaced with small molecules and/or surfactants.
Optionally, carbon dioxide released by the cells is removed from the extra-capillary space of the bioreactor 150 through the gas transfer membranes 102b. To assist in the removal of carbon dioxide, the pressure inside of the gas transfer membranes 102b may be less than the static head pressure inside of the bioreactor 150 or less than atmospheric pressure. The gas transfer membranes 150 may have manufactured pores, for example of 30 Angstroms or less or 40 Angstroms or less in size, or may be dense walled. Optionally, at least at some times, oxygen enriched air is supplied through the gas transfer membranes 102a. This increases the partial pressure of oxygen, which may counteract a reduced total pressure inside of the gas transfer membranes 102a such that oxygen still diffuses into the extra-capillary space of the bioreactor 150 while carbon dioxide is removed. The oxygen concentration of supplied air, the pressure of supplied air and/or the flow rate of supplied air may be varied over time to alter the amount of oxygen delivered to the extra-capillary space of the bioreactor 150. For example, the amount of oxygen delivered may be increased over time to deliver oxygen at a higher rate when cells, or a population of cells, are maturing.
In some examples, the bioreactor 150 is used to grow cells in suspension. Cells in suspension can move in the extra-capillary space, typically because they are entrained in a flow of a liquid moving within the extra-capillary space. The flow can be induced by various methods such as one or more of: a mixer, such as mixer 160; flowing liquids into and out of the extra-capillary space for example by way of fittings 164; or, rocking, spinning or otherwise moving the bioreactor 150. The cells can be suspended alone, or attached to carriers that are also in suspension. The cells may be, for example, stem cells, CD34+ cells, RBCs or any other cells mentioned herein, including eukaryotic, microbial or plant cells. In other examples, the bioreactor 150 is used to grow adherent cells.
In some examples, a portion of the cells may be restrained within small spaces such as the gaps between adjacent membranes 102 within a zone 104, 106, 108, 110, particularly within compound zones having oblique or perpendicular sets of membranes 102 such as within compound zones 104/108 104/110, 106/108 and 106/110. Optionally, such a restraint may effect only a portion of the cells in the bioreactor 150 while other cells circulate more freely through the parts of zones 104, 106, 108, 110 with membranes in only one direction, or through larger gaps such as gaps between groups of membranes 102, for example gaps between zones 104, 106, 108, 110, or gaps between membranes 102 or zones 104, 106, 108, 110 and interior surfaces of walls of the bioreactor 150. Alternatively or additionally, such a restraint may be temporary. For example, a collection of restrained cells may emerge towards the end of a cell growth period but be dislodged for (i.e. just before or during) a harvest phase of a process. In some examples, at least a portion of the restrained cells is maintained in the bioreactor 150 while other cells are harvested. These restrained cells can, for example, function to seed the bioreactor for a subsequent growth phase in a batch process, or maintain a population of cells in the bioreactor 150 despite harvesting in a continuous or semi-continuous process. The degree of restraint may be modified, for example, by modifying the spacing between membranes 102, the tension or slack of the membranes 102 and whether the membranes 102 are woven together or merely overlap each other. Optionally, a reactor 150 may be used to grow adhered or retained cells and suspended cells at the same time.
In some examples, cells that are restrained within small spaces in the bioreactor may build matrices around themselves. Even if these matrices do not materially adhere the cells to the membranes 102 they can, over time, inhibit removal of cells within the matrix from a membrane zone. To control the average age of restrained cells, a dislodging force can be applied periodically to remove some or all of the restrained cells. The dislodging force can be applied, for example, in one or more episodes during a growth phase, or before or during a harvesting phase. The dislodging force can be created, for example, by temporarily increasing the power of a mixer, flushing a liquid through the extra-capillary space of the bioreactor 150, introducing bubbles (for example of nitrogen) into the extra-capillary space, moving the bioreactor 150, temporarily changing the direction of a mixer, or temporarily changing the inlet and/or outlet location of a liquid added to the extra-capillary space, for example by way of fittings 164. Optionally, cells can also be dislodged by using a chemical or enzymatic treatment or by inducing a change in an environmentally responsive material of the membranes 102.
Maintaining at least a portion of the cells in suspension, or dislodging restrained cells, produces mechanical stress on the membranes 102. Optionally, the outside diameter of the membranes 102 may be 0.5 mm or more, 0.7 mm or more or 1.0 mm or more. Larger diameter membranes 102 are able to withstand more mechanical stress than smaller diameter membranes. At longer lengths between potting heads 142, for example 20 cm or more, larger diameter membranes 102 may also provide a more nearly even distribution of nutrients. Alternatively or additionally, the membranes 102 may be reinforced, for example by being coated on a tubular braid, or made by being made in a thermally induced phase separation (TIPS) process.
The ability to grow and harvest cells, for example to keep at least a portion of the cells in suspension or to dislodge restrained cells, is also enhanced by having a controlled spacing between membranes 102 and/or a low packing density. The packing density of membranes 102 within a zone or compound zone (measured as sum of the cross-sectional areas of the membranes divided by cross-sectional area of the zones) may be 25% or less, 20% or less, or 15% or less. In addition, gaps can be provided, as shown for example in
The diameter of the element 140 shown in
Optionally, an element 140 may have additional divisions among the membrane 102 to create more zones. For example, the element 140 of
The elements 140 of
In either orientation, circulation within the bioreactor 150 or movement of the bioreactor 150 may be provided to generally homogenize one or more operating parameters in the bioreactor. Alternatively, one or more operating parameters may be intentionally varied, for example along the height/length of the bioreactor 150, across the width/diameter of the bioreactor 150, or in a radial direction extending outwards from a central longitudinal axis of the bioreactor 150. An operating parameter may be a parameter measured in the extra-capillary space, for example, temperature, pH or the concentration of a compound such as dissolved oxygen or a nutrient. Alternatively, an operating parameter may relate to the transfer of a compound to or from membranes 102. Alternatively the operating parameter may relate to the strength of circulation, or the time or extent to which cells are permitted to be restrained within a zone rather than freely circulating.
Although some of the examples herein relate to suspension cell cultures, the bioreactor 150 can also be used to grow adherent cells. In addition to any other method or apparatus element described herein to help dislodge adhered cells, thermo-responsive materials on the membranes 102 may also be activated to help dislodge the cells.
The element 140 described above is formed in mold. Braces 114 are optionally part of the mold, but otherwise the element 140 is separated from the mold before being assembled into the reactor 150. Optionally, some or all of a mold may remain as part of an element.
Further examples bioreactor and methods of making them are described below.
A second element 402 produced in the mold 400 may be similar to an element 140 as shown in
In the example shown in
Referring to
The second element 402 has two apertures 410 on opposed sides of the second element 402. Optionally one or both of the apertures 410 include an additional feature, for example a raised ring in the example shown. Alternatively, an aperture 410 maybe a simple opening in the mold 400. Optionally, the outside diameter of one of the apertures 410 is generally the same as the inside diameter of the other aperture 410. Multiple second elements 402 can be stacked together by inserting the smaller aperture 410 of a second element 402 into the larger aperture of another second element 402. Optionally, the apertures 410 of two or more second elements 402 are connected by an adhesive or solvent bonded together. Alternatively, the apertures 410 may be threaded such that two or more second elements 402 may be screwed together, or two apertures 410 may be press fit together.
In the example shown, the mold 400 has four potting chambers 416 where potting material 428 will be added. Optionally, during the potting process the potting material 428 (shown for example in
As shown in
The membrane plate assemblies 426 may be customized, for example, by having one or more of selected membrane 102 type or size, a selected spacing between membranes 102 in a membrane plate assembly 426, a selected spacing between membrane plate assemblies 126, a selected taut or slack mounting of the membranes 102, or selected treatments of membranes 102, for example to may them protein fouling resistant or environmentally (i.e. thermally) responsive. By changing the membrane plate assemblies 426, a second element 402, second reactor 450 or compound reactor 550 may be produced that is suitable for use for growing a variety of cells or cell products. In some examples, the number of perfusion membranes 102a relative to the number of gas transfer membranes 102b is altered, only perfusion membranes 102a are provided, or only gas transfer membranes 102b are provided in a second element 402, second reactor 450 or compound reactor 550.
In the example shown, the membranes 102 are inset from the sidewalls of the potting chamber 416. Alternatively, membranes 102 may be placed closer to the sidewalls of the potting chamber 416. The size of the panels 408 (either their absolute size or their size relative to the size of the mold 400) may be varied, or the panels 408 may be removed. The example shown is for a relatively small mold 400 with a roughly 10-15 cm outside diameter. In a larger mold 400, for example with an outside diameter up to 30 cm or more or 60 cm or more, panels 408 of essentially the same absolute size may be used but the panels 408 will be relatively smaller in the larger mold 400. Accordingly, a portion of the volume of extra-capillary space that is not crossed by membranes 102 can be reduced (or increased). However, it is not always necessary or desirable to have more of the extra-capillary space crossed by membranes 102.
Having multiple potting chambers 416 divides the amount of potting material 428 into smaller units, which can help with managing the heat generated when the potting material 428 cures, and also facilitates having the panels 408 not covered with potting material 428. Optionally, particularly if the panels 408 are not required for example for sensors or to enhance mixing, the mold 400 may be re-configured to provide one continuous potting chamber 416.
Referring to
Referring to
The top plate 436 may have one or more adapters 442. In one example, an adapter 442 is used to attach a sensor body connected to a fiber optic cable in a hole in the top plate 436. The fiber optic cable is used to read a sensor dot attached to the inside of the sensor body in the adapter 442. Sensor dots are made, for example, by PreSens and can be used to measure pH, dissolved oxygen concentration, dissolved carbon dioxide concentration or other aspects of the extra-capillary space. Alternatively, an adapter 442 may be used to support another type of probe or sensor.
The second reactor 450 has one or more sensors L, M, N in communication with the ECS through the top plate 436. In the example shown, sensors L, M, N sense the pH, dissolved oxygen concentration and dissolved carbon dioxide concentration of the first media in the extra-capillary space. Optionally, each sensor L, M, N is attached to an adapter 442 over a hole in the top plate 436. The sensor L, M, N has a probe body that is sealed to the adapter 442. The probe body has a sensor dot that is in liquid communication with the first media in the ECS. The adapter 442 also holds a fiber optic cable 628 (shown in
One or more gasses are provided to the second reactor 450 from one or more compressed gas tanks 602. In the example shown, there are compressed gas tanks 602 for oxygen, carbon dioxide, nitrogen and air. The gasses flow through tubing into a gas mixer 604, which produces a gas blend. The gas blend passes through tubing past one or more inline sensors 606 and through an inline gas filter 608 to a cap 430 of the second reactor 450. In the example shown, inline sensors 606 I and J sense the oxygen concentration and temperature of the gas blend. The gas blend flows from the cap 430, through gas transfer membranes 102b inside the second reactor 450, to an opposing cap 430. The gas blend then flows through more tubing, another in line gas filter 608 and one or more additional inline sensors 606 to an off-gas analyzer 610. In the example shown, inline sensor K senses the temperature of the gas blend leaving the second reactor 450. In the example shown, the off-gas analyzer measures the carbon dioxide concentration and the oxygen concentration of the gas blend.
Optionally, a flow control valve may be provided before or after the second reactor 450 to control the flow rate of gas through the second reactor 450. Where a compound reactor 550 is used as the second reactor 450, the tubing to and from the compound reactor 550 may be connected to a gas perfusion manifold 534 and gas perfusion header 536, optionally with control valves 538, as described in relation to
A second media is provided to the second reactor 450 from a spinner flask 616. Optionally, second media may be added to the spinner flask 616 from a bottle 620 connected to a peristaltic pump 618. Second media may also be removed from the spinner flask 616 by another peristaltic pump 618 connected to another bottle 620. Second media is drawn from the spinner flask 616 by another peristaltic pump 618 and passes through one or more inline sensors 606 to a cap 430 of the second reactor 450. In the example shown, inline sensors 606 A, B, C and D sense the dissolved oxygen concentration, pH, dissolved carbon dioxide concentration and temperature of the second media. The second media flows from the cap 430, through perfusion membranes 102a inside the second reactor 450, to an opposing cap 430. The second media then flows through more tubing and one or more additional inline sensors 606 back to the spinner flask 616. In the example shown, inline sensors 606 E, F, G, and H sense the dissolved oxygen concentration, pH, dissolved carbon dioxide concentration and temperature of the second media leaving the second reactor 450. Filtered gas vents 612 are provided to allow air to move in and out of the second media system while preventing contamination of the second media.
Optionally, a flow control valve may be provided before or after the second reactor 450 to control the flow rate of second media through the second reactor 450. Where a compound reactor 550 is used as the second reactor 450, the tubing to and from the compound reactor 550 may be connected to a liquid perfusion manifold 530 and gas perfusion header 532, optionally with control valves 538, as described in relation to
Optionally, the inline sensors 606 for pH, carbon dioxide concentration and oxygen concentration may be optical inline sensors. For example, optical inline sensors from PreSens have a fiber optic cable 628 connected to a fiber optic meter 634 as shown in
The cell culture system 600 shown is a small-scale system. Larger systems may be made, for example to operate a larger compound reactors 550, or to operate multiple second reactors 450 or multiple compound reactors 550 in parallel. A larger or other system can use different sizes or types of equipment or different arrangements of conduits, valves, flow control devices, sensors, pumps, heaters or other equipment than the cell culture system 600 to achieve similar functions.
Although the second media circulates outside of the second reactor 450, in contrast circulation of the first media is preferably minimized. Optionally there is no circulation of first media outside of the second reactor 450. The first media differs from the second media as determined by the pore size of the perfusion membranes 102a. In some examples, the perfusion membranes 102a may have a molecular weight cut off (MWCO) selected in the range of 5,000 to 250,000 Da. Cells, virus, and molecules above the MWCO are retained in the first media. Large molecules retained in the extra-capillary space can include, for example, growth factors and proteins. In some examples, the first media contains large molecules, such as growth factors, that materially affect the cost of a cell culture process. By retaining these large molecules in the first media, and minimizing or eliminating circulation of the first media outside of the second reactor 450, the amount of these large molecule that are required to operate a process is reduced. Retaining large molecules or other products of the process in a limited volume of the first media can also help with harvesting these products. Since the membranes 102 exclude cells, they also prevent any contamination, for example by bacteria, in the gas or second media parts of the system from contaminating product cells or product producing cells in the extra-capillary space.
Despite the separation of the first media into the extra-capillary space by the membranes 102, the second media and gasses can influence the first media. For example, the flow of a gas or second media through the membranes 102 can be used to cool (or heat) the first media. The carbon dioxide concentration and pH of the first media can be influenced, for example, by acids, bases or buffers provided to the first media through the perfusion membranes 102a or by adding or removing carbon dioxide from the first media through the gas transfer membranes 102b. Some nutrients, with sizes small enough to pass through the pores of the perfusion membranes 102a, can also be provided to the first media from the second media. Small cell respiration products, which may be inhibitory, can also be removed from the first media by diffusion into the second media through the perfusion membranes 102a.
In some cases with the gas system shown in
Erythroid precursor cells tend to expand faster and differentiate into red blood cells under low oxygen partial pressure. A high oxygen transfer capacity (kLa) is needed to support a large and/or rapidly growing population of cells. However, the oxygen transfer is preferably not driven by having areas of high dissolved oxygen concentration in direct communication with cells in the ECS. The gas transfer membranes 102b assist in maintaining a hypoxic environment in the ECS that still supports a high cell density by providing oxygen transfer that is well controlled and generally homogenously distributed throughout the extra-capillary space.
Products are typically harvested from a bioreactor by withdrawing media containing the product through a simple port. In some examples, after separating a harvested component, the non-harvested components may be returned to the reactor. Even with such recycle, it is likely that some useful material is lost from the media and the volume of media required is increased by the volume of the harvesting loop. Optionally, a harvest layer 300 can be configured to provide one or more separation steps. For example, in the case of cultured red blood cells, a suspension of cells may be removed from a reactor and separated in a first step into a) enucleated cells and b) a mixture of nucleated cells and nuclei. The mixture may be separated in a second step to extract the nucleated cells for recycle to the reactor from the nuclei, which are waste. Optionally, the harvest layer 300 is configured to perform part of the first step, i.e. nucleated cells are selectively retained in the reactor while enucleated cells are selectively extracted from the reactor. The degree of separation does not need to be a complete separation to be useful and a second separation of enucleated cells from nucleated cells may occur outside of the reactor. In another example, where the bioreactor 150, 450, 550 is used to produce virus in cells, the produced virus may be extracted through the harvest layer 300 while the cells are retained in the bioreactor. In another example, where cells in the bioreactor 150, 450, 550 are used to produce a protein or other product, the product may be extracted through the harvest layer 300 while the cells are retained in the bioreactor 150, 450, 550.
In batch filtration, the extra-capillary space (ECS) is filled initially to a generally constant volume. In a fed-batch process, the ECS is filled to an initial volume. At one or more later times, media is added to the ECS (without removing media). In a continuous process, media is added and removed continuously (which could include, for example, in pulses or at other discrete time intervals). However, the continuous process may also be operated such that the volume of the ECS in the reactor remains generally constant or such that the volume of the media in the ECS changes, for example increases, over time.
The turn down ratio of a bioreactor is the ratio of the largest volume of media that can be in the reactor while it is operating to the smallest volume of media that can be in the reactor while it is operating. In the reactors 150, 550 herein, the turn down ratio is determined based on the volume of media in the ECS. A large turn down ratio can be useful in some processes because, for example, a small number of cells can be used to inoculate the reactor 150, 550 at a high density. It is not necessary to inoculate the entire reactor volume. As the cell population increases, more media is added to dilute the ECS to a desired cell density. In a reactor 150, 550 as described herein with multiple elements 140 or second elements 402, turn down is enabled by shutting down the perfusion, and optionally gas, flow to elements 140 or second elements 402 that are not yet filled with media in their ECS. For example, a first element 140 or second element 402 at the bottom of the reactor 150, 550 may be filled with first media and inoculated. Later, first media is added to the ECS to submerge one or more other elements 140 or second elements 402. The valves related to these elements 140 or second elements 402 are then opened to provide perfusion and/or gas exchange to the newly submerged elements 140 or second elements 402. The reactor 150, 550 can thus be operated in a fed-batch mode or generally with perfusion and with a variable amount of media in the ECS.
In another mode of operation multiple reactors 150, 450, 550 can be operated with distinct ECSs but with their membranes 102 linked. For example the second media perfusion and/or gas perfusion ports of multiple reactors 150, 450, 550 can be connected in parallel. Because of the membranes 102, cells in the ECS of one reactor 150, 450, 550 cannot enter the ECS of another reactor 150, 450, 550. In that way cells of the same type but drawn from different donors or intended for different patients can be cultured simultaneously but separately. Although each cell population is different in some way, the cell population dynamics are sufficiently similar such that some second media perfusion or gas supply system components can be shared. Optionally the flow of second media or gas to an individual reactor 150, 450, 550 may be adjusted in a way analogous to the control of individual second elements 402 in a compound reactor 550 as described above.
The membranes 102 provide perfusion, i.e. delivery of a substance in a distributed manner. The membranes 102 also provide retention, i.e. the cells are retained in the ECS. The membranes 102 can also retain selected compounds in the ECS. This can decrease the amount of expensive elements, such as growth factors, that are required since the ECS is smaller than the entire bioreactor 150, 450, 550 and its recirculation loops. As these selected compounds are consumed or degrade, more of the selected compound can be added directly to the ECS without the addition of whole media. In this way, compounds that degrade at different rates can be added at appropriate rates.
A reactor 150, 450, 550 can be cooled (or heated) by cooling the second media or gas. This can make the reactor 150, 450, 550 more accessible than, for example, wrapping a reactor in a cooling jacket. Further, with a cooling jacket as reactor diameter increases there may be a temperature difference between the core and the jacket. With cooling delivered through the membranes 102, heat is removed from the center of the reactor 150, 450, 550.
The mixers 160 provide bulk mixing but also disrupt boundary layers around the membranes 102. This disruption may increase a transfer rate associated with the membranes 102, but also tends to homogenize the transfer rates in different parts of the reactor. Even if cells are adhered to the membranes 102, or physically collected by a net of membranes 102, the first media moves, which helps to homogenize the delivery of gas and second media components. In a compound reactor 550 with multiple mixers, the mixer type, pitch or diameter can be varied within the compound reactor 550 to inhibit the formation of dead zones that do not have material movement of the first media. Movement of the first media can also be provided by moving the whole reactor 150, 450, 550, for example by rotation about any axis, rocking back and forth, inversion, rotation on an incline, or another movement that changes the direction of the gravity vector relative to the reactor 150, 450, 550.
ExampleIn an experimental example, a reactor similar to the second reactor 450 of
The impeller was rotated at between 50 and 150 RPM. The first media and the second media were the same. The media was supplied to the perfusion membranes from a peristaltic pump operating at 34 mL/min. The gasses were mixed to 8% CO2 and drawn from a pressure break upstream of the reactor and through the gas transfer membranes by a pump downstream of the reactor at 100 mL/minute. The reactor was maintained at a temperature of 37 C by controlling the temperature of a hydroponic tent containing the reactor and other equipment. The reactor was sterilized in an autoclave for 30 minutes at 121 C.
The ECS of the reactor was filled with media and innoculated over a 24 hour period to an initial total cell density (TCD) and viable cell density (VCD) of 0.66*106 per mL and 0.63*106 per mL respectively. The flow of gas to the perfusion membranes and media to the perfusion media were commenced and continued for another three days. During the four day run, the pH of the media in the extra-capillary decreased from 7.6 to 6.9 indicating that cells were growing. TCD and VCD of 0.70*106 per mL and 0.41*106 per mL respectively were measured in media sampled from the extra-capillary space at the end of the trial. Shaking the reactor released clumps of cells from the membrane matrix. TCD and VCD of 1.42*106 per mL and 0.90*106 per mL respectively were measured in media sampled from the extra-capillary space after the shaking. The bioreactor was dismantled and additional clumps were observed still present within the hollow fiber membrane matrix, particularly in compound zones where the perfusion membranes overlapped with gas transfer membranes. The cell count data is not considered quantitatively accurate since the counts were made in an automated cell counter and cells in the clumps were not counted. However, the cell count data, pH data and presence of uncounted clumps of cells indicate that cells reproduced in the bioreactor. Further, viable cells were present both in suspension and restrained within the hollow fiber membrane matrix.
The description above provides several examples of reactors, parts of reactors, methods of making reactors and systems and processes to growing cells in the reactors. Any one or more aspects of one example may be combined with any one or more aspects of one or more other examples to provide further examples of reactors, parts of reactors, methods of making reactors and systems and processes to growing cells in the reactors.
Claims
1. A cell culture bioreactor comprising a plurality of zones wherein each of the zones has one or more membranes and wherein a flow of a fluid to each of the zones is separately controllable.
2. The bioreactor of claim 1 comprising a plurality of sensors associated with the plurality of zones.
3. The bioreactor of claim 1 comprising one or more fluid control modules in communication with the plurality of zones.
4. The bioreactor of claim 1 comprising a plurality of sensors configured to collect data through transparent windows of the bioreactor.
5. The bioreactor of claim 4 comprising a moving data collector.
6. The bioreactor of claim 1 having an aperture to hold an optical sensor body in a hole through a wall of the bioreactor.
7. The bioreactor of claim 1 having a mixer or a plurality of elements in a stack, each of the plurality of elements having associated membranes.
8. The bioreactor of claim 7 having ports to supply one or more gaseous and/or a liquid media separately to the membranes of an element.
9. The bioreactor of claim 1 having multiple mixers spaced along the height of the bioreactor.
10. The bioreactor of claim 1 having a magnetic base plate coupled to a motor for rotating the bioreactor.
11. The bioreactor of claim 1 having a based plate with a mixer, the mixer comprising a magnetic material.
12. The bioreactor of claim 1 wherein the membrane diameter is 0.5 mm or more, membranes are arranged in layers with spaces between adjacent layers, membranes are spaced apart by at least 0.2 mm in layers, membrane packing density in a zone or compound zone is 25% or less, the membranes are arranged in spaced apart zones, or the membranes are arranged in a pattern of zones, compound zones and open spaces.
13. The bioreactor of claim 1 having one or more elements, an element including membranes potted in a mold wherein portions of the mold remain with the element and define upper and lower surfaces of the element.
14. The bioreactor of claim 13 wherein upper or lower surface of a portion of the mold associated with an element are joined to a portion of a mold associated with another element, a base, a top plate, a harvest layer or a mixing layer.
15. The bioreactor of claim 13 wherein the mold is adapted to locate a membrane assembly inserted into the mold.
16. The bioreactor of claim 13 wherein surfaces of the mold generally parallel with the membranes comprise apertures.
17. The bioreactor of claim 13 comprising panels separating potting cavities of the mold.
18. A method of making a bioreactor comprising,
- providing a plurality of membrane plates assembles comprising hollow fiber membranes having a controlled spacing;
- inserting the plurality of membrane plate assemblies in a first part of a mold, wherein a portions of the ends of the membrane plate assemblies are located within portions of the mold;
- attaching a second part of the mold to the first part of the mold to form potting cavities around the ends of the membrane plate assemblies;
- adding liquid potting material to the potting cavities;
- curing the potting material;
- removing a portion of the mold and the potting material to expose lumens at the cut ends of the membranes; and,
- placing caps over the ends of the membranes, thereby forming an element.
19. The process of claim 18 comprising attaching a portion of the mold of a first element to a portion of a mold of a second element, wherein the extra-capillary space of the first element is in communication with the extra capillary space of the second element.
20. The process of claim 18 wherein a portion of the mold generally parallel to the membranes comprises an aperture and the method comprising attaching a plate to the aperture.
Type: Application
Filed: Feb 4, 2021
Publication Date: Aug 5, 2021
Inventors: Shane Alexander Jaques KILPATRICK (Mississauga), Scott Raymond PUNDSACK (Georgetown), Andrew Michael PUNDSACK (Georgetown)
Application Number: 17/168,085